Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation
US8546408B2 · kind B2 · utility
17Cited by
36References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 2010 |
| Grant date | Oct 1, 2013 |
| Priority date | — |
| Expiry date | Dec 22, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Fused heteroaryl pyridyl benzenesulfonamides are provided that act as potent antagonists of the CCR2 receptor. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases and as controls in assays for the identification of CCR2 antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.